Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, E.
Right arrow Articles by Connor, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, E.
Right arrow Articles by Connor, T.
American Journal of Health-System Pharmacy, Vol 53, Issue 22, 2713-2723
Copyright © 1996 by American Society of Health-System Pharmacists

Articles

Monitoring occupational exposure to cancer chemotherapy drugs

ES Baker and TH Connor


Reports of the health effects of handling cytotoxic drugs and compliance with guidelines for handling these agents are briefly reviewed, and studies using analytical and biological methods of detecting exposure are evaluated. There is little conclusive evidence of detrimental health effects from occupational exposure to cytotoxic drugs. Work practices have improved since the issuance of guidelines for handling these drugs, but compliance with the recommended practices is still inadequate. Of 64 reports published since 1979 on studies of workers' exposure to these drugs, 53 involved studies of changes in cellular or molecular endpoints (biological markers) and 12 described chemical analyses of drugs or their metabolites in urine (2 involved both, and 2 reported the same study). The primary biological markers used were urine mutagenicity, sister chromatid exchange, and chromosomal aberrations; other studies involved formation of micronuclei and measurements of urinary thioethers. The studies had small sample sizes, and the methods were qualitative, nonspecific, subject to many confounders, and possibly not sensitive enough to detect most occupational exposures. Since none of the currently available biological and analytical methods is sufficiently reliable or reproducible for routine monitoring of exposure in the workplace, further studies using these methods are not recommended; efforts should focus instead on wide-spread implementation of improved practices for handling cytotoxic drugs.
 



This article has been cited by other articles:


Home page
 J Oncol Pharm PractHome page
Section 1 Introduction
Journal of Oncology Pharmacy Practice, September 1, 2007; 13(3_suppl): 3 - 6.
[PDF]

Home page
 Integr Cancer TherHome page
P. Venkatesh, B. Shantala, G. C. Jagetia, K. K. Rao, and M. S. Baliga
Modulation of Doxorubicin-Induced Genotoxicity by Aegle marmelos in Mouse Bone Marrow: A Micronucleus Study
Integr Cancer Ther, March 1, 2007; 6(1): 42 - 53.
[Abstract] [PDF]

Home page
 CA Cancer J ClinHome page
T. H. Connor and M. A. McDiarmid
Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings
CA Cancer J Clin, November 1, 2006; 56(6): 354 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
ASHP Guidelines on Handling Hazardous Drugs
Am. J. Health Syst. Pharm., June 15, 2006; 63(12): 1172 - 1191.
[Full Text] [PDF]

Home page
 J Oncol Pharm PractHome page
T. H Connor and Q. Xiang
The effect of isopropyl alcohol on the permeation of gloves exposed to antineoplastic agents
Journal of Oncology Pharmacy Practice, September 1, 2000; 6(3): 109 - 114.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society of Health-System Pharmacists.